IGI Seminar Series – Correction of the Sickle Cell Disease Mutation with CRISPR-Cas9 @innovativegenomicsinstitute
IGI Seminar Series – Correction of the Sickle Cell Disease Mutation with CRISPR-Cas9  @innovativegenomicsinstitute
Uploaded July 2021 | Updated November 2026, 1 day ago
UCLA project scientist Mark DeWitt discusses a combined IGI, UCLA, and UCSF effort in developing a CRISPR-based clinical product to correct sickle cell disease. Listen to Mark as he describes how his team went from a bench genome-editing protocol to an accepted Investigational New Drug (IND).

IGI Seminar Series - May 4, 2021
IGI Seminar Series – Correction of the Sickle Cell Disease Mutation with CRISPR-Cas9Why Jenny Hamilton dropped everything to fight COVID-19CRISPR Applications in Plants — Dr. Dan Voytas (2016 IGI CRISPR Workshop)Rohan Sachdeva on the power of a shared goal in IGI’s COVID-19 testing workCRISPR-Based Diagnostic Tools - A CRISPR Whiteboard LessonGene Therapy with Nucleases — Dr. Fyodor Urnov (2015 IGI CRISPR Workshop)CRISPR Applications in Mice — Dr. Lin He (2016 IGI CRISPR Workshop)What Motivates Navneet Matharu – IGIs HS Chau Women in Enterprising Science FellowshipWhat Britt Glaunsinger hopes her new research will reveal about SARS-CoV-2Abby Stahl on helping volunteers at the IGIs COVID-19 diagnostic testing labPanel - GEMs in the Environment and BiomanufacturingIntroduction to CRISPR-Cas9 Genome Editing
Innovative Genomics Institute – IGI |

IGI Seminar Series – Correction of the Sickle Cell Disease Mutation with CRISPR-Cas9

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER